Sriram Yennu

University Of Tx Md Anderson Can Ctr

$3,268,567

Attributed

$3,268,567

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $711.1K · FY2018–23

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$3,268,567 · 3

By mechanism

R01$2,483,796 · 1

R21$784,771 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Eduardo Bruera$4,706,548

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsAnxietyQuality Of LifeCancer PatientMental DepressionSymptomsRandomizedResearch DesignEffective TherapyInsightStandard CareHospitalsEtiologyPsychological DistressRadiation TherapyBaseBrainModalityArea Under CurveDisabling SymptomMoodsSeveritiesCancer InterventionInflammation